BÜHLMANN has become the prime calprotectin company within a few years, offering the broadest calprotectin product range with the automatable BÜHLMANN fCAL® ELISA and the quantitative Quantum Blue® Calprotectin rapid tests and the new immuno-turbidimetric BÜHLMANN fCAL® turbo assay. For automation on ELISA robots we will continuously offer new CE-marked protocols for our BÜHLMANN fCAL® ELISA, combined with our easy, safe and clean stool sampling and extraction CALEX® Cap device. With IBDoc® calprotectin, the smartphone based home testing solution, BÜHLMANN is bringing calprotectin monitoring to patients. In 2016, BÜHLMANN has launched its newest innovation the Quantum Blue® Infliximab rapid test allowing clinicians immediate determination of trough levels.
BÜHLMANN does not only stand for calprotectin, but also for a selection of unique, high-quality assays for clinical routine use such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing, and the BÜHLMANN GanglioCombi™ MAG ELISA , the only screening ELISA for anti-Ganglioside and anti-MAG antibody testing in one single assay.
BÜHLMANN continues to renew and enlarge its product portfolio, with the aim to be a leader in selected fields of in vitro diagnostics and in combining innovation with its traditional core values.
As unique as our products are our distribution fields with leading suppliers in the field of molecular diagnostics. With Seegene and the Anyplex™ II/Allplex™ products in combination with NIMBUS IVD/STARlet and the CFX96, we offer the leading automated high multiplex real-time PCR solution, with a unique menu, for all sizes of laboratories. With EntroGen we offer outstanding MDx tests in the field of Oncology.
BÜHLMANN Laboratories AG
Baselstr. 55
4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
E-Mail: info@buhlmannlabs.ch
Social Links